🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Tuesday's Top Insider Moves: Execs Buy and Sell Big in US Stocks

EditorFrank DeMatteo
Published 04/12/2024, 15:02
© Reuters.

This article summarizes the most significant insider buying and selling activities reported on Tuesday for US stocks.

Top Insider Buys:

• Impact Biomedical Inc. (NASDAQ:IBO): Frank D. Heuszel, the Chief Executive Officer, purchased 500 shares at $2.61 per share, totaling $1,305. This acquisition comes as the stock has experienced a 16% decline over the past week. Heuszel now directly owns 96,844 shares, demonstrating continued confidence in the company's prospects. Impact Biomedical recently secured a new U.S. patent for an insect repelling composition, expanding its 3F™ technology platform.

• Accelerate Diagnostics, Inc. (NASDAQ:AXDX): John Patience, a director, acquired 200,000 shares at $1.57 each, totaling $314,000. The shares were purchased in a private transaction from another board member. Following this acquisition, Patience holds 653,224 shares through the John Patience Living Trust, 3,941 shares in an IRA, and 214,046 shares through Patience Enterprises LP. This significant purchase comes as the stock has shown mixed performance, falling 60% year-to-date but gaining 35% over the past six months.

• Maximus, Inc. (NYSE:NYSE:MMS): Director Gayathri Rajan acquired 73.185 shares at an average price of $73.719 per share, totaling approximately $5,395. These shares were acquired through dividend reinvestment. Additionally, Rajan received 7.159 dividend equivalent rights tied to previously awarded restricted stock units. In a separate transaction, Director Warren Michael J. purchased 16.555 shares at $73.72 each through dividend reinvestment, increasing his direct ownership to 4,084.685 shares.

Top Insider Sells:

• Aeva Technologies, Inc. (NYSE:AEVA): CEO Soroush Salehian Dardashti sold 240,000 shares worth approximately $1.06 million. The transactions were executed under a pre-established Rule 10b5-1 trading plan, with shares sold at weighted average prices ranging from $4.35 to $4.49.

Arlo Technologies , Inc. (NYSE:NYSE:ARLO): CEO Matthew Blake sold 316,644 shares at an average price of $11.54 per share, totaling approximately $3.65 million. This transaction was conducted to satisfy estimated tax withholding obligations upon the settlement of Performance Stock Units.

Palantir Technologies Inc . (NYSE:NASDAQ:PLTR): CTO and Executive VP Shyam Sankar executed significant stock transactions, selling shares worth a total of $367.9 million at an average price of $70.0782. These sales were part of a preexisting Rule 10b5-1 trading plan.

• Netflix Inc. (NASDAQ:NFLX): Executive Chairman Reed Hastings sold shares worth approximately $43.36 million, with transaction prices ranging from $885.66 to $901.54 per share. The sales were part of a pre-established trading plan under Rule 10b5-1.

• CorVel Corp (NASDAQ:CRVL): Chairman of the Board Gordon Clemons sold 8,000 shares in two separate transactions, with prices ranging from $365.0511 to $367.5. The total value of these transactions amounted to approximately $2.9 million.

Investors should stay tuned to insider buying and selling activities as they can provide valuable insights into a company's prospects. While insider transactions alone should not be the sole basis for investment decisions, they can offer clues about management's confidence in the company's future performance and potential upcoming developments. However, it's important to consider these moves in conjunction with other fundamental and technical analysis factors before making any investment choices.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.